Pier Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57,504
| Closed | -$2.31M | – | 129 |
|
|
2024
Q4 | $2.31M | Sell |
57,504
-31,643
| -35% | -$1.27M | 0.33% | 86 |
|
|
2024
Q3 | $5.64M | Buy |
89,147
+31,908
| +56% | +$2.02M | 0.8% | 70 |
|
|
2024
Q2 | $3.03M | Sell |
57,239
-2,420
| -4% | -$128K | 0.45% | 94 |
|
|
2024
Q1 | $4.89M | Buy |
+59,659
| New | +$4.89M | 0.67% | 71 |
|
|
2018
Q4 | – | Sell |
-305,350
| Closed | -$5.32M | – | 123 |
|
|
2018
Q3 | $5.32M | Sell |
305,350
-274,503
| -47% | -$4.78M | 0.67% | 86 |
|
|
2018
Q2 | $5.5M | Buy |
+579,853
| New | +$5.5M | 0.76% | 90 |
|